Home › Chronic Lymphocytic Leukemia › Florida › Miami
Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Miami, FL
9 pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Miami (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Nagre-recruitPhase 2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Nagre-recruitPhase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Nagre-recruitPhase 1/2
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Nagre-recruitPhase 3
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Nagre-recruitPhase 3
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1
- University of Miami, Miami
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Nagre-recruitPhase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Nagre-recruitPhase 4
- Sylvester Comprehensive Cancer Center, Miami
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Nagre-recruitPhase 4
- Sylvester Comprehensive Cancer Center, Miami
Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod
- Boston, MA31 pag-aaral
- Columbus, OH29 pag-aaral
- Durham, NC28 pag-aaral
- Washington, DC22 pag-aaral
- Seattle, WA22 pag-aaral
- Rochester, MN20 pag-aaral
- New York City, NY20 pag-aaral
- Houston, TX18 pag-aaral
- Baldwin Park, CA18 pag-aaral
- Cincinnati, OH15 pag-aaral
- Milwaukee, WI15 pag-aaral
- Chicago, IL14 pag-aaral
Iba pang pag-aaral sa Miami
- Kanser sa Suso42 pag-aaral
- Kanser (lahat ng uri)36 pag-aaral
- Non-Small Cell Lung Cancer35 pag-aaral
- Kanser sa Prostate30 pag-aaral
- Obesity28 pag-aaral
- Kanser sa Ovary24 pag-aaral
- Acute Myeloid Leukemia24 pag-aaral
- Overweight23 pag-aaral
- Metastatic Cancer22 pag-aaral
- Multiple Myeloma22 pag-aaral
- Kanser sa Baga22 pag-aaral
- Sakit ni Alzheimer21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.